FDA Inspection
Exela Pharma Sciences LLCExela Pharma Sciences LLC – FDA Inspection, Oct 27, 2017
Record Details
This FDA Inspection record concerns Exela Pharma Sciences LLC, with an inspection on October 27, 2017, issued by the Atlanta District Office, covering human drugs.
View Company Profile
ID · 77fbff66-b4da-433d-8b4e-ee9f4a64f845
Inspection Facts
- Inspection number
- 1032076
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Exela Pharma Sciences LLC
13| Date | Classification | Office | Project area |
|---|---|---|---|
| November 15, 2024 | OAI | Drug Quality Assurance | |
| July 18, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 29, 2019 | VAI | Atlanta District Office | Generic Drug Evaluation |
| December 19, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 11, 2018 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Exela Pharma Sciences LLC
- FDA Inspection 1256957 - 2024-11-15
- FDA Inspection 1096634 - 2019-07-18
- FDA Inspection 1084304 - 2019-03-29
- FDA Inspection 1081405 - 2018-12-19
- FDA Inspection 1067755 - 2018-09-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.